John Lewis, Oisin Biotechnologies, presents at Undoing Aging 2018, Exploring Selective Therapies for Killing Senescent Cells

John Lewis, the CSO of Oisin biotechnologies, giving a presentation at
John Lewis, the CTO of Oisin Biotechnologies, presents their work in developing very specific therapies to kill senescence cell.

Accelerating rejuvenation treatments to repair damage caused by aging. Berlin, March, 15 — 17.


Leave a Reply

Your email address will not be published. Required fields are marked *